Publicaciones en colaboración con investigadores/as de University of Glasgow (5)

2024

  1. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

    Heart

2022

  1. Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

    European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331

2019

  1. Biomarkers of Cardiovascular Disease

    Textbook of Vascular Medicine (Springer International Publishing), pp. 319-330

2017

  1. Novel urinary peptidomic classifier predicts incident heart failure

    Journal of the American Heart Association, Vol. 6, Núm. 8

2015

  1. Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study

    International Journal of Cardiology, Vol. 185, pp. 177-185